Cart
sales@molnova.com
FN075
CAS No. 864405-82-3
FN075 ( FN 075 )
Catalog No. M16269 CAS No. 864405-82-3
FN075 is a small-molecule inhibitor targeting Escherichia coli amyloid biogenesis and biofilm formation.
Purity : >98% (HPLC)
COA
Datasheet
HNMR
HPLC
MSDS
Handing Instructions
| Size | Price / USD | Stock | Quantity |
| 100MG | Get Quote | Get Quote |
|
| 200MG | Get Quote | Get Quote |
|
| 500MG | Get Quote | Get Quote |
|
| 1G | Get Quote | Get Quote |
|
Biological Information
-
Product NameFN075
-
NoteResearch use only, not for human use.
-
Brief DescriptionFN075 is a small-molecule inhibitor targeting Escherichia coli amyloid biogenesis and biofilm formation.
-
DescriptionFN075 is a small-molecule inhibitor targeting Escherichia coli amyloid biogenesis and biofilm formation; stimulates α-synuclein amyloid fiber formation; significantly attenuates virulence in a mouse model of urinary tract infection.
-
SynonymsFN 075
-
PathwayGPCR/G Protein
-
TargetAntibacterial
-
RecptorAntibacterial
-
Research Area——
-
Indication——
Chemical Information
-
CAS Number864405-82-3
-
Formula Weight481.49
-
Molecular FormulaC26H18F3NO3S
-
Purity>98% (HPLC)
-
Solubility——
-
SMILES——
-
Chemical Name(R)-7-(naphthalen-1-ylmethyl)-5-oxo-8-(3-(trifluoromethyl)phenyl)-2,3-dihydro-5H-thiazolo[3,2-a]pyridine-3-carboxylic acid
Shipping & Storage Information
-
Storage(-20℃)
-
ShippingWith Ice Pack
-
Stability≥ 2 years
Reference
1. Cegelski L, et al. Nat Chem Biol. 2009 Dec;5(12):913-9.
2. Clark MA, et al. Nat Chem Biol. 2009 Sep;5(9):647-54.
3. Nors Perdersen M, et al. Sci Rep. 2015 May 28;5:10422.
2. Clark MA, et al. Nat Chem Biol. 2009 Sep;5(9):647-54.
3. Nors Perdersen M, et al. Sci Rep. 2015 May 28;5:10422.
molnova catalog
related products
-
Delpazolid
A novel oxazolidinone antibiotic that shows good antibacterial activity (MSSA MIC50=1 ug/mL).
-
Comanthoside B
Comanthoside B is a natural product isolated from the aerial portions of Ruellia tuberosa L with anti-inflammatory and antiseptic activities.
-
Praeruptorin A（b）
Praeruptorin A has the potential to inhibit migration/fusion of preosteoclasts in vitro and bone erosion in vivo by targeting calmodulin and inhibiting the Ca(2+)/calmodulin-CaMKIV-CREB-NFATc1 and/or Ca(2+)/calmodulin-calcineurin-NFATc1 signaling axis.
